Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2015, Article ID 587193, 15 pages
http://dx.doi.org/10.1155/2015/587193
Review Article

TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis

Department of Health Sciences, Program in Biological Sciences, European University Cyprus, 6 Diogenes Street, Engomi, 1516 Nicosia, Cyprus

Received 21 August 2014; Accepted 14 October 2014

Academic Editor: Apostolos Zaravinos

Copyright © 2015 Panagiotis Papageorgis. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Derynck and R. J. Akhurst, “Differentiation plasticity regulated by TGF-β family proteins in development and disease,” Nature Cell Biology, vol. 9, no. 9, pp. 1000–1004, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. L. M. Wakefield and C. S. Hill, “Beyond TGFβ: roles of other TGFβ superfamily members in cancer,” Nature Reviews Cancer, vol. 13, no. 5, pp. 328–341, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Massagué, J. Seoane, and D. Wotton, “Smad transcription factors,” Genes and Development, vol. 19, no. 23, pp. 2783–2810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Massagué and R. R. Gomis, “The logic of TGFβ signaling,” FEBS Letters, vol. 580, no. 12, pp. 2811–2820, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Annes, J. S. Munger, and D. B. Rifkin, “Making sense of latent TGFβ activation,” Journal of Cell Science, vol. 116, no. 2, pp. 217–224, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. P.-E. Gleizes, R. C. Beavis, R. Mazzieri, B. Shen, and D. B. Rifkin, “Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-β binding protein-1 that mediates bonding to the latent transforming growth factor-β1,” Journal of Biological Chemistry, vol. 271, no. 47, pp. 29891–29896, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Miyazono, A. Olofsson, P. Colosetti, and C.-H. Heldin, “A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1,” The EMBO Journal, vol. 10, no. 5, pp. 1091–1101, 1991. View at Google Scholar · View at Scopus
  8. J. Saharinen, J. Taipale, and J. Keski-Oja, “Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1,” EMBO Journal, vol. 15, no. 2, pp. 245–253, 1996. View at Google Scholar · View at Scopus
  9. C. Unsöld, M. Hyytiäinen, L. Bruckner-Tuderman, and J. Keski-Oja, “Latent TGF-β binding protein LTBP-1 contains three potential extracellular matrix interacting domains,” Journal of Cell Science, vol. 114, no. 1, pp. 187–197, 2001. View at Google Scholar · View at Scopus
  10. I. Nunes, P.-E. Gleizes, C. N. Metz, and D. B. Rifkin, “Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β,” Journal of Cell Biology, vol. 136, no. 5, pp. 1151–1163, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. D. A. Lawrence, R. Pircher, C. Kryceve-Martinerie, and P. Jullien, “Normal embryo fibroblasts release transforming growth factors in a latent form,” Journal of Cellular Physiology, vol. 121, no. 1, pp. 184–188, 1984. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Crawford, V. Stellmach, J. E. Murphy-Ullrich et al., “Thrombospondin-1 is a major activator of TGF-β1 in vivo,” Cell, vol. 93, no. 7, pp. 1159–1170, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. F. Ribeiro, M. Poczatek, S. Schultz-Cherry, M. Villain, and J. E. Murphy-Ullrich, “The activation sequence of thrombospondin-1 interacts with the latency- associated peptide to regulate activation of latent transforming growth factor-β,” Journal of Biological Chemistry, vol. 274, no. 19, pp. 13586–13593, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. C. M. Dubois, M.-H. Laprise, F. Blanchette, L. E. Gentry, and R. Leduc, “Processing of transforming growth factor β1 precursor by human furin convertase,” Journal of Biological Chemistry, vol. 270, no. 18, pp. 10618–10624, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Sato and D. B. Rifkin, “Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture,” Journal of Cell Biology, vol. 109, no. 1, pp. 309–315, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. Yu and I. Stamenkovic, “Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis,” Genes and Development, vol. 14, no. 2, pp. 163–176, 2000. View at Google Scholar · View at Scopus
  17. J. S. Munger, X. Huang, H. Kawakatsu et al., “The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis,” Cell, vol. 96, no. 3, pp. 319–328, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Lyons, J. Keski-Oja, and H. L. Moses, “Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium,” Journal of Cell Biology, vol. 106, no. 5, pp. 1659–1665, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Barcellos-Hoff, R. Derynck, M. L.-S. Tsang, and J. A. Weatherbee, “Transforming growth factor-β activation in irradiated murine mammary gland,” Journal of Clinical Investigation, vol. 93, no. 2, pp. 892–899, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. P.-J. Wipff, D. B. Rifkin, J.-J. Meister, and B. Hinz, “Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix,” The Journal of Cell Biology, vol. 179, no. 6, pp. 1311–1323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. G. J. Riggins, S. Thiagalingam, E. Rozenblum et al., “Mad-related genes in the human,” Nature Genetics, vol. 13, no. 3, pp. 347–349, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Lagna, A. Hata, A. Hemmati-Brivanlou, and J. Massague, “Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways,” Nature, vol. 383, no. 6603, pp. 832–836, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Nakao, T. Imamura, S. Souchelnytskyi et al., “TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4,” EMBO Journal, vol. 16, no. 17, pp. 5353–5362, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Derynck, Y. Zhang, and X.-H. Feng, “Smads: transcriptional activators of TGF-β responses,” Cell, vol. 95, no. 6, pp. 737–740, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Massague, “TGF-beta signal transduction,” Annual Review of Biochemistry, vol. 67, pp. 753–791, 1998. View at Google Scholar
  26. C.-H. Heldin, K. Miyazono, and P. ten Dijke, “TGF-β signalling from cell membrane to nucleus through SMAD proteins,” Nature, vol. 390, no. 6659, pp. 465–471, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. M. P. De Caestecker, P. Hemmati, S. Larisch-Bloch, R. Ajmera, A. B. Roberts, and R. J. Lechleider, “Characterization of functional domains within Smad4/DPC4,” The Journal of Biological Chemistry, vol. 272, no. 21, pp. 13690–13696, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Hata, Y. Shi, and J. Massagué, “TGF-β signaling and cancer: structural and functional consequences of mutations in Smads,” Molecular Medicine Today, vol. 4, no. 6, pp. 257–262, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Shi, Y.-F. Wang, L. Jayaraman, H. Yang, J. Massagué, and N. P. Pavletich, “Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling,” Cell, vol. 94, no. 5, pp. 585–594, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Wotton, R. S. Lo, S. Lee, and J. Massagué, “A smad transcriptional corepressor,” Cell, vol. 97, no. 1, pp. 29–39, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Zhang, X.-H. Feng, R.-Y. Wu, and R. Derynck, “Receptor-associated Mad homologues synergize as effectors of the TGF-β response,” Nature, vol. 383, no. 6596, pp. 168–172, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Bierie and H. L. Moses, “Tumour microenvironment: TGFΒ: the molecular Jekyll and Hyde of cancer,” Nature Reviews Cancer, vol. 6, no. 7, pp. 506–520, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. K. A. Lewis, P. C. Gray, A. L. Blount et al., “Betaglycan binds inhibin and can mediate functional antagonism of activin signalling,” Nature, vol. 404, no. 6776, pp. 411–414, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Gougos and M. Letarte, “Primary structure of endoglin, and RGD-containing glycoprotein of human endothelial cells,” The Journal of Biological Chemistry, vol. 265, no. 15, pp. 8361–8364, 1990. View at Google Scholar · View at Scopus
  35. S. H. Wong, L. Hamel, S. Chevalier, and A. Philip, “Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-β signalling receptors,” European Journal of Biochemistry, vol. 267, no. 17, pp. 5550–5560, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Y. Li, L. K. Sorensen, B. S. Brooke et al., “Defective angiogenesis in mice lacking endoglin,” Science, vol. 284, no. 5419, pp. 1534–1537, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. J. L. Wrana, L. Attisano, R. Wieser, F. Ventura, and J. Massagué, “Mechanism of activation of the TGF-β receptor,” Nature, vol. 370, no. 6488, pp. 341–347, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. P. ten Dijke, H. Yamashita, H. Ichijo et al., “Characterization of type I receptors for transforming growth factor-β and activin,” Science, vol. 264, no. 5155, pp. 101–104, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Shi and J. Massagué, “Mechanisms of TGF-β signaling from cell membrane to the nucleus,” Cell, vol. 113, no. 6, pp. 685–700, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Derynck and Y. E. Zhang, “Smad-dependent and Smad-independent pathways in TGF-β family signalling,” Nature, vol. 425, no. 6958, pp. 577–584, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. H. E. Olivey, N. A. Mundell, A. F. Austin, and J. V. Barnett, “Transforming growth factor-β stimulates epithelial-mesenchymal transformation in the proepicardium,” Developmental Dynamics, vol. 235, no. 1, pp. 50–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Lebrin, M. Deckers, P. Bertolino, and P. Ten Dijke, “TGF-β receptor function in the endothelium,” Cardiovascular Research, vol. 65, no. 3, pp. 599–608, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. J. S. Desgrosellier, N. A. Mundell, M. A. McDonnell, H. L. Moses, and J. V. Barnett, “Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation,” Developmental Biology, vol. 280, no. 1, pp. 201–210, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. Y.-T. Lai, K. B. Beason, G. P. Brames et al., “Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation,” Developmental Biology, vol. 222, no. 1, pp. 1–11, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. P. J. Miettinen, R. Ebner, A. R. Lopez, and R. Derynck, “TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors,” The Journal of Cell Biology, vol. 127, no. 6, pp. 2021–2036, 1994. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Miyazono, S. Maeda, and T. Imamura, “BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk,” Cytokine and Growth Factor Reviews, vol. 16, no. 3, pp. 251–263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Souchelnytskyi, P. Ten Dijke, K. Miyazono, and C.-H. Heldin, “Phosphorylation of ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses,” The EMBO Journal, vol. 15, no. 22, pp. 6231–6240, 1996. View at Google Scholar · View at Scopus
  48. M. Huse, T. W. Muir, L. Xu, Y.-G. Chen, J. Kuriyan, and J. Massagué, “The TGFβ receptor activation process: an inhibitor- to substrate-binding switch,” Molecular Cell, vol. 8, no. 3, pp. 671–682, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. R. S. Lo, Y. G. Chen, Y. Shi, N. P. Pavletich, and J. Massague, “The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-β receptors,” EMBO Journal, vol. 17, no. 4, pp. 996–1005, 1998. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Abdollah, M. Macías-Silva, T. Tsukazaki, H. Hayashi, L. Attisano, and J. L. Wrana, “TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling,” Journal of Biological Chemistry, vol. 272, no. 44, pp. 27678–27685, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Tsukazaki, T. A. Chiang, A. F. Davison, L. Attisano, and J. L. Wrana, “SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor,” Cell, vol. 95, no. 6, pp. 779–791, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. X.-H. Feng, Y. Zhang, R.-Y. Wu, and R. Derynck, “The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation,” Genes and Development, vol. 12, no. 14, pp. 2153–2163, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Janknecht, N. J. Wells, and T. Hunter, “TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300,” Genes and Development, vol. 12, no. 14, pp. 2114–2119, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Itoh, J. Ericsson, J. Nishikawa, C. H. Heldin, and P. ten Dijke, “The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling,” Nucleic Acids Research, vol. 28, pp. 4291–4298, 2000. View at Publisher · View at Google Scholar
  55. R.-Y. Bai, C. Koester, T. Ouyang et al., “SMIF, a Smad4-interacting protein that functions as a co-activator in TGFβ signalling,” Nature Cell Biology, vol. 4, no. 3, pp. 181–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. C.-R. Chen, Y. Kang, P. M. Siegel, and J. Massagué, “E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression,” Cell, vol. 110, no. 1, pp. 19–32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Kang, C.-R. Chen, and J. Massagué, “A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells,” Molecular Cell, vol. 11, no. 4, pp. 915–926, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Wotton, P. S. Knoepfler, C. D. Laherty, R. N. Eisenman, and J. Massagué, “The Smad transcriptional corepressor TGIF recruits mSin3,” Cell Growth and Differentiation, vol. 12, no. 9, pp. 457–463, 2001. View at Google Scholar · View at Scopus
  59. S. Akiyoshi, H. Inoue, J.-I. Hanai et al., “c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads,” The Journal of Biological Chemistry, vol. 274, no. 49, pp. 35269–35277, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Luo, S. L. Stroschein, W. Wang et al., “The Ski oncoprotein interacts with the Smad proteins to repress TGF̄ signaling,” Genes and Development, vol. 13, no. 17, pp. 2196–2206, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. S. L. Stroschein, W. Wang, S. Zhou, Q. Zhou, and K. Luo, “Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein,” Science, vol. 286, no. 5440, pp. 771–774, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Sun, X. Liu, E. N. Eaton, W. S. Lane, H. F. Lodish, and R. A. Weinberg, “Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling,” Molecular Cell, vol. 4, no. 4, pp. 499–509, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Seoane, H.-V. Le, L. Shen, S. A. Anderson, and J. Massagué, “Integration of smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation,” Cell, vol. 117, no. 2, pp. 211–223, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Pardali, A. Kurisaki, A. Morén, P. Ten Dijke, D. Kardassis, and A. Moustakas, “Role of Smad proteins and transcription factor Sp1 in p21Waf1/Cip1 regulation by transforming growth factor-β,” Journal of Biological Chemistry, vol. 275, no. 38, pp. 29244–29256, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Zhang, X.-H. Feng, and R. Derynck, “Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription,” Nature, vol. 394, no. 6696, pp. 909–913, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. X. Lin, Y.-Y. Liang, B. Sun et al., “Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription,” Molecular and Cellular Biology, vol. 23, no. 24, pp. 9081–9093, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Peng, S. Zhao, L. Song, M. Wang, and K. Jiao, “Sertad1 encodes a novel transcriptional co-activator of SMAD1 in mouse embryonic hearts,” Biochemical and Biophysical Research Communications, vol. 441, no. 4, pp. 751–756, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Izutsu, M. Kurokawa, Y. Imai, K. Maki, K. Mitani, and H. Hirai, “The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling,” Blood, vol. 97, no. 9, pp. 2815–2822, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. Q. Xi, Z. Wang, A. Zaromytidou et al., “A poised chromatin platform for TGF-β access to master regulators,” Cell, vol. 147, no. 7, pp. 1511–1524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Ross, E. Cheung, T. G. Petrakis, M. Howell, W. L. Kraus, and C. S. Hill, “Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription,” The EMBO Journal, vol. 25, no. 19, pp. 4490–4502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Papageorgis, A. W. Lambert, S. Ozturk et al., “Smad signaling is required to maintain epigenetic silencing during breast cancer progression,” Cancer Research, vol. 70, no. 3, pp. 968–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Nakao, M. Afrakhte, A. Morén et al., “Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling,” Nature, vol. 389, no. 6651, pp. 631–635, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Itoh, M. Landström, A. Hermansson et al., “Transforming growth factor β1 induces nuclear export of inhibitory Smad7,” Journal of Biological Chemistry, vol. 273, no. 44, pp. 29195–29201, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Hayashi, S. Abdollah, Y. Qiu et al., “The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling,” Cell, vol. 89, no. 7, pp. 1165–1173, 1997. View at Publisher · View at Google Scholar · View at Scopus
  75. T. Ebisawa, M. Fukuchi, G. Murakami et al., “Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation,” The Journal of Biological Chemistry, vol. 276, no. 16, pp. 12477–12480, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Kavsak, R. K. Rasmussen, C. G. Causing et al., “Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation,” Molecular Cell, vol. 6, no. 6, pp. 1365–1375, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Zhang, T. Fei, L. Zhang et al., “Smad7 antagonizes transforming growth factor β signaling in the nucleus by interfering with functional Smad-DNA complex formation,” Molecular and Cellular Biology, vol. 27, no. 12, pp. 4488–4499, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. W. He, D. C. Dorn, H. Erdjument-Bromage, P. Tempst, M. A. S. Moore, and J. Massagué, “Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFβ pathway,” Cell, vol. 125, no. 5, pp. 929–941, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Descargues, A. K. Sil, Y. Sano et al., “IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 7, pp. 2487–2492, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. E. Zhang, “Non-Smad pathways in TGF-β signaling,” Cell Research, vol. 19, no. 1, pp. 128–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. M. T. Hartsough and K. M. Mulder, “Transforming growth factor β activation of p44mapk in proliferating cultures of epithelial cells,” Journal of Biological Chemistry, vol. 270, no. 13, pp. 7117–7124, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. R. S. Frey and K. M. Mulder, “TGFβ regulation of mitogen-activated protein kinases in human breast cancer cells,” Cancer Letters, vol. 117, no. 1, pp. 41–50, 1997. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Papageorgis, K. Cheng, S. Ozturk et al., “Smad4 inactivation promotes malignancy and drug resistance of colon cancer,” Cancer Research, vol. 71, no. 3, pp. 998–1008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. G. A. Finlay, V. J. Thannickal, B. L. Fanburg, and K. E. Paulson, “Transforming growth factor-β1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor,” Journal of Biological Chemistry, vol. 275, no. 36, pp. 27650–27656, 2000. View at Publisher · View at Google Scholar · View at Scopus
  85. F. Viñals and J. Pouysségur, “Transforming growth factor β1 (TGF-β1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-α signaling,” Molecular and Cellular Biology, vol. 21, no. 21, pp. 7218–7230, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. V. Ellenrieder, S. F. Hendler, W. Boeck et al., “Transforming growth factor β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation,” Cancer Research, vol. 61, no. 10, pp. 4222–4228, 2001. View at Google Scholar · View at Scopus
  87. L. Xie, B. K. Law, A. M. Chytil, K. A. Brown, M. E. Aakre, and H. L. Moses, “Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro,” Neoplasia, vol. 6, no. 5, pp. 603–610, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Lawler, X.-H. Feng, R.-H. Chen et al., “The type II transforming growth factor-β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues,” Journal of Biological Chemistry, vol. 272, no. 23, pp. 14850–14859, 1997. View at Publisher · View at Google Scholar · View at Scopus
  89. A. J. Galliher and W. P. Schiemann, “Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion,” Cancer Research, vol. 67, no. 8, pp. 3752–3758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. M. K. Lee, C. Pardoux, M. C. Hall et al., “TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA,” EMBO Journal, vol. 26, no. 17, pp. 3957–3967, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. J. H. Liao, J. S. Chen, M. Q. Chai, S. Zhao, and J. G. Song, “The involvement of p38 MAPK in transforming growth factor β1-induced apoptosis in murine hepatocytes,” Cell Research, vol. 11, no. 2, pp. 89–94, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. N. Kimura, R. Matsuo, H. Shibuya, K. Nakashima, and T. Taga, “BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6,” Journal of Biological Chemistry, vol. 275, no. 23, pp. 17647–17652, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. A. V. Bakin, C. Rinehart, A. K. Tomlinson, and C. L. Arteaga, “p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration,” Journal of Cell Science, vol. 115, no. 15, pp. 3193–3206, 2002. View at Google Scholar · View at Scopus
  94. B. A. Hocevar, T. L. Brown, and P. H. Howe, “TGF-β induces fibronectin synthesis through a C-jun N-terminal kinase-dependent, Smad4-independent pathway,” EMBO Journal, vol. 18, no. 5, pp. 1345–1356, 1999. View at Publisher · View at Google Scholar · View at Scopus
  95. L. Yu, M. C. Hébert, and Y. E. Zhang, “TGF-β receptor-activated p38 MAP kinase mediates smad-independent TGF-β responses,” The EMBO Journal, vol. 21, no. 14, pp. 3749–3759, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Yamaguchi, K. Shirakabe, H. Shibuya et al., “Identification of a member of the MAPKKK family as a potential Mediator of TGF-β signal transduction,” Science, vol. 270, no. 5244, pp. 2008–2011, 1995. View at Publisher · View at Google Scholar · View at Scopus
  97. J.-H. Shim, C. Xiao, A. E. Paschal et al., “TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo,” Genes and Development, vol. 19, no. 22, pp. 2668–2681, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Yamashita, K. Fatyol, C. Jin, X. Wang, Z. Liu, and Y. E. Zhang, “TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β,” Molecular Cell, vol. 31, no. 6, pp. 918–924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Sorrentino, N. Thakur, S. Grimsby et al., “The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner,” Nature Cell Biology, vol. 10, no. 10, pp. 1199–1207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. L. Zhang, W. Wang, Y. Hayashi et al., “A role for MEK kinase 1 in TGF-β/activin-induced epithelium movement and embryonic eyelid closure,” EMBO Journal, vol. 22, no. 17, pp. 4443–4454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. K.-Y. Kim, B.-C. Kim, Z. Xu, and S.-J. Kim, “Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-β-induced apoptosis in hepatoma cells,” The Journal of Biological Chemistry, vol. 279, no. 28, pp. 29478–29484, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. A. V. Bakin, A. K. Tomlinson, N. A. Bhowmick, H. L. Moses, and C. L. Arteaga, “Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration,” Journal of Biological Chemistry, vol. 275, no. 47, pp. 36803–36810, 2000. View at Publisher · View at Google Scholar · View at Scopus
  103. I. Shin, A. V. Bakin, U. Rodeck, A. Brunet, and C. L. Arteaga, “Transforming growth factor β enhances epithelial cell survival via Akt-dependent regulation of FKHRL1,” Molecular Biology of the Cell, vol. 12, no. 11, pp. 3328–3339, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Y. Jae, I. Shin, and C. L. Arteaga, “Type I transforming growth factor β receptor binds to and activates phosphatidylinositol 3-kinase,” Journal of Biological Chemistry, vol. 280, no. 11, pp. 10870–10876, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Hidalgo and E. K. Rowinsky, “The rapamycin-sensitive signal transduction pathway as a target for cancer therapy,” Oncogene, vol. 19, no. 56, pp. 6680–6686, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Lamouille and R. Derynck, “Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway,” Journal of Cell Biology, vol. 178, no. 3, pp. 437–451, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. A. B. Jaffe and A. Hall, “Rho GTPases: biochemistry and biology,” Annual Review of Cell and Developmental Biology, vol. 21, pp. 247–269, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. N. A. Bhowmick, M. Ghiassi, A. Bakin et al., “Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism,” Molecular Biology of the Cell, vol. 12, no. 1, pp. 27–36, 2001. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Edlund, M. Landström, C.-H. Heldin, and P. Aspenström, “Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA,” Molecular Biology of the Cell, vol. 13, no. 3, pp. 902–914, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. B. Tang, M. Vu, T. Booker et al., “TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression,” The Journal of Clinical Investigation, vol. 112, no. 7, pp. 1116–1124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. L. M. Wakefield and A. B. Roberts, “TGF-β signaling: positive and negative effects on tumorigenesis,” Current Opinion in Genetics and Development, vol. 12, no. 1, pp. 22–29, 2002. View at Publisher · View at Google Scholar · View at Scopus
  112. P. M. Siegel, W. Shu, R. D. Cardiff, W. J. Muller, and J. Massagué, “Transforming growth factor β signaling impairs neu-induced mammary tumorigenesis while promoting pulmonary metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8430–8435, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. A. B. Roberts and L. M. Wakefield, “The two faces of transforming growth factor β in carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8621–8623, 2003. View at Publisher · View at Google Scholar · View at Scopus
  114. P. M. Siegel and J. Massagué, “Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer,” Nature Reviews Cancer, vol. 3, no. 11, pp. 807–820, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. M. E. Choi and B. J. Ballermann, “Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors,” The Journal of Biological Chemistry, vol. 270, no. 36, pp. 21144–21150, 1995. View at Publisher · View at Google Scholar · View at Scopus
  116. K. M. Hyman, G. Seghezzi, G. Pintucci et al., “Transforming growth factor-β1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase,” Surgery, vol. 132, no. 2, pp. 173–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  117. J. N. Rich, M. Zhang, M. B. Datto, D. D. Bigner, and X.-F. Wang, “Transforming growth factor-β-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines,” The Journal of Biological Chemistry, vol. 274, no. 49, pp. 35053–35058, 1999. View at Publisher · View at Google Scholar · View at Scopus
  118. X. Yang, J. J. Letterio, R. J. Lechleider et al., “Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β,” The EMBO Journal, vol. 18, no. 5, pp. 1280–1291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Laiho, J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massagué, “Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation,” Cell, vol. 62, no. 1, pp. 175–185, 1990. View at Publisher · View at Google Scholar · View at Scopus
  120. G. J. Hannon and D. Beach, “p15INK4B is a potential effector of TGF-β-induced cell cycle arrest,” Nature, vol. 371, no. 6494, pp. 257–261, 1994. View at Publisher · View at Google Scholar · View at Scopus
  121. M. B. Datto, Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X.-F. Wang, “Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 12, pp. 5545–5549, 1995. View at Publisher · View at Google Scholar · View at Scopus
  122. K. Polyak, J.-Y. Kato, M. J. Solomon et al., “P27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest,” Genes and Development, vol. 8, no. 1, pp. 9–22, 1994. View at Publisher · View at Google Scholar · View at Scopus
  123. C. Sandhu, J. Garbe, N. Bhattacharya et al., “Transforming growth factor β stabilizes p15(INK4B) protein, increases p15(INK4B)-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells,” Molecular and Cellular Biology, vol. 17, no. 5, pp. 2458–2467, 1997. View at Google Scholar · View at Scopus
  124. I. Reynisdottir, K. Polyak, A. Iavarone, and J. Massague, “Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β,” Genes and Development, vol. 9, no. 15, pp. 1831–1845, 1995. View at Publisher · View at Google Scholar · View at Scopus
  125. I. Reynisdóttir and J. Massagué, “The subcellular locations of pl5(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2,” Genes and Development, vol. 11, no. 4, pp. 492–503, 1997. View at Publisher · View at Google Scholar · View at Scopus
  126. J. A. Pietenpol, R. W. Stein, E. Moran et al., “TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains,” Cell, vol. 61, no. 5, pp. 777–785, 1990. View at Publisher · View at Google Scholar · View at Scopus
  127. J. D. Norton, “ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis,” Journal of Cell Science, vol. 113, no. 22, pp. 3897–3905, 2000. View at Google Scholar · View at Scopus
  128. J. Seoane, C. Pouponnot, P. Staller, M. Schader, M. Eilers, and J. Massagué, “TGFβ influences myc, miz-1 and smad to control the CDK inhibitor p15INK4b,” Nature Cell Biology, vol. 3, no. 4, pp. 400–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  129. P. Staller, K. Peukert, A. Kiermaier et al., “Repression of p15INK4b expression by Myc through association with Miz-1,” Nature Cell Biology, vol. 3, no. 4, pp. 392–399, 2001. View at Publisher · View at Google Scholar · View at Scopus
  130. A. Lasorella, M. Noseda, M. Beyna, Y. Yokota, and A. Iavarone, “Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins,” Nature, vol. 407, pp. 592–598, 2000. View at Google Scholar
  131. X.-J. Wang, K. M. Liefer, S. Tsai, B. W. O'Malley, and D. R. Roop, “Development of gene-switch transgenic mice that inducibly express transforming growth factor β1 in the epidermis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 15, pp. 8483–8488, 1999. View at Publisher · View at Google Scholar · View at Scopus
  132. X.-J. Wang, D. A. Greenhalgh, J. R. Bickenbach et al., “Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 6, pp. 2386–2391, 1997. View at Publisher · View at Google Scholar · View at Scopus
  133. G. S. Ashcroft, X. Yang, A. B. Glick et al., “Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response,” Nature Cell Biology, vol. 1, no. 5, pp. 260–266, 1999. View at Publisher · View at Google Scholar · View at Scopus
  134. D. F. Pierce Jr., M. D. Johnson, Y. Matsui et al., “Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1,” Genes and Development, vol. 7, no. 12, pp. 2308–2317, 1993. View at Publisher · View at Google Scholar · View at Scopus
  135. C. Jhappan, A. G. Geiser, E. C. Kordon et al., “Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation,” EMBO Journal, vol. 12, no. 5, pp. 1835–1845, 1993. View at Google Scholar · View at Scopus
  136. A. E. Gorska, H. Joseph, R. Derynck, H. L. Moses, and R. Serra, “Dominant-negative interference of the transforming growth factor β type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice,” Cell Growth and Differentiation, vol. 9, no. 3, pp. 229–238, 1998. View at Google Scholar · View at Scopus
  137. E. P. Böttinger, J. L. Jakubczak, D. C. Haines, K. Bagnall, and L. M. Wakefield, “Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene,” Cancer Research, vol. 57, no. 24, pp. 5564–5570, 1997. View at Google Scholar · View at Scopus
  138. P. L. Beck, I. M. Rosenberg, R. J. Xavier, T. Koh, J. F. Wong, and D. K. Podolsky, “Transforming growth factor-β mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells,” The American Journal of Pathology, vol. 162, no. 2, pp. 597–608, 2003. View at Publisher · View at Google Scholar · View at Scopus
  139. K. Pardali and A. Moustakas, “Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1775, no. 1, pp. 21–62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  140. C.-W. Jang, C.-H. Chen, C.-C. Chen, J.-Y. Chen, Y.-H. Su, and R.-H. Chen, “TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase,” Nature Cell Biology, vol. 4, no. 1, pp. 51–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  141. R. Perlman, W. P. Schiemann, M. W. Brooks, H. F. Lodish, and R. A. Weinberg, “TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation,” Nature Cell Biology, vol. 3, no. 8, pp. 708–714, 2001. View at Publisher · View at Google Scholar · View at Scopus
  142. J. Yoo, M. Ghiassi, L. Jirmanova et al., “Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation,” The Journal of Biological Chemistry, vol. 278, no. 44, pp. 43001–43007, 2003. View at Publisher · View at Google Scholar · View at Scopus
  143. Y. Gottfried, A. Rotem, R. Lotan, H. Steller, and S. Larisch, “The mitochondrial ARTS protein promotes apoptosis through targeting XIAP,” EMBO Journal, vol. 23, no. 7, pp. 1627–1635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Ohgushi, S. Kuroki, H. Fukamachi et al., “Transforming growth factor β-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells,” Molecular and Cellular Biology, vol. 25, no. 22, pp. 10017–10028, 2005. View at Publisher · View at Google Scholar · View at Scopus
  145. A. B. Roberts, M. A. Anzano, L. M. Wakefield, N. S. Roche, D. F. Stern, and M. B. Sporn, “Type β transforming growth factor: a bifunctional regulator of cellular growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 1, pp. 119–123, 1985. View at Publisher · View at Google Scholar · View at Scopus
  146. G. R. Grotendorst, “Connective tissue growth factor: a mediator of TGf-β action on fibroblasts,” Cytokine and Growth Factor Reviews, vol. 8, no. 3, pp. 171–179, 1997. View at Publisher · View at Google Scholar · View at Scopus
  147. K. Park, S.-J. Kim, Y.-J. Bang et al., “Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 19, pp. 8772–8776, 1994. View at Publisher · View at Google Scholar · View at Scopus
  148. I. Y. Kim, H.-J. Ahn, D. J. Zelner et al., “Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells,” Cancer Research, vol. 56, no. 1, pp. 44–48, 1996. View at Google Scholar · View at Scopus
  149. S. Markowitz, J. Wang, L. Myeroff et al., “Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability,” Science, vol. 268, no. 5215, pp. 1336–1338, 1995. View at Publisher · View at Google Scholar · View at Scopus
  150. G. J. Riggins, K. W. Kinzler, B. Vogelstein, and S. Thiagalingam, “Frequency of Smad gene mutations in human cancers,” Cancer Research, vol. 57, no. 13, pp. 2578–2580, 1997. View at Google Scholar · View at Scopus
  151. M. Schutte, R. H. Hruban, L. Hedrick et al., “DPC4 gene in various tumor types,” Cancer Research, vol. 56, no. 11, pp. 2527–2530, 1996. View at Google Scholar · View at Scopus
  152. K. Eppert, S. W. Scherer, H. Ozcelik et al., “MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma,” Cell, vol. 86, no. 4, pp. 543–552, 1996. View at Publisher · View at Google Scholar · View at Scopus
  153. S. A. Hahn, A. T. M. S. Hoque, C. A. Moskaluk et al., “Homozygous deletion map at 18q21.1 in pancreatic cancer,” Cancer Research, vol. 56, no. 3, pp. 490–494, 1996. View at Google Scholar · View at Scopus
  154. S. A. Hahn, M. Schutte, A. T. M. Shamsul Hoque et al., “DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1,” Science, vol. 271, no. 5247, pp. 350–353, 1996. View at Publisher · View at Google Scholar · View at Scopus
  155. S. Thiagalingam, C. Lengauer, F. S. Leach et al., “Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers,” Nature Genetics, vol. 13, no. 3, pp. 343–346, 1996. View at Publisher · View at Google Scholar · View at Scopus
  156. I. Schwarte-Waldhoff, O. V. Volpert, N. P. Bouck et al., “Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 17, pp. 9624–9629, 2000. View at Publisher · View at Google Scholar · View at Scopus
  157. M. Kretzschmar, J. Doody, I. Timokhina, and J. Massagué, “A mechanism of repression of TGFfβ/Smad signaling by oncogenic Ras,” Genes and Development, vol. 13, no. 7, pp. 804–816, 1999. View at Publisher · View at Google Scholar · View at Scopus
  158. M. Kretzschmar, J. Doody, and J. Massagué, “Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1,” Nature, vol. 389, no. 6651, pp. 618–622, 1997. View at Publisher · View at Google Scholar · View at Scopus
  159. J. Massagué, “Integration of Smad and MAPK pathways: a link and a linker revisited,” Genes and Development, vol. 17, no. 24, pp. 2993–2997, 2003. View at Publisher · View at Google Scholar · View at Scopus
  160. R. R. Gomis, C. Alarcón, C. Nadal, C. Van Poznak, and J. Massagué, “C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells,” Cancer Cell, vol. 10, no. 3, pp. 203–214, 2006. View at Publisher · View at Google Scholar · View at Scopus
  161. D. Padua, X. H.-F. Zhang, Q. Wang et al., “TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4,” Cell, vol. 133, no. 1, pp. 66–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  162. A. J. Minn, G. P. Gupta, P. M. Siegel et al., “Genes that mediate breast cancer metastasis to lung,” Nature, vol. 436, no. 7050, pp. 518–524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  163. N. Mori, M. Morishita, T. Tsukazaki et al., “Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor β signaling through interaction with CREB-binding protein/p300,” Blood, vol. 97, no. 7, pp. 2137–2144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  164. J. Deheuninck and K. Luo, “Ski and SnoN, potent negative regulators of TGF-β signaling,” Cell Research, vol. 19, no. 1, pp. 47–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. J. P. Their, “Epithelial-mesenchymal transitions in tumor progression,” Nature Reviews Cancer, vol. 2, no. 6, pp. 442–454, 2002. View at Publisher · View at Google Scholar · View at Scopus
  166. J. Xu, S. Lamouille, and R. Derynck, “TGF-β-induced epithelial to mesenchymal transition,” Cell Research, vol. 19, no. 2, pp. 156–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  167. J. P. Thiery and J. P. Sleeman, “Complex networks orchestrate epithelial-mesenchymal transitions,” Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 131–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  168. A. Cano, M. A. Pérez-Moreno, I. Rodrigo et al., “The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression,” Nature Cell Biology, vol. 2, no. 2, pp. 76–83, 2000. View at Publisher · View at Google Scholar · View at Scopus
  169. P. Savagner, K. M. Yamada, and J. P. Thiery, “The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition,” Journal of Cell Biology, vol. 137, no. 6, pp. 1403–1419, 1997. View at Publisher · View at Google Scholar · View at Scopus
  170. A. Eger, K. Aigner, S. Sonderegger et al., “DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells,” Oncogene, vol. 24, no. 14, pp. 2375–2385, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. J. Comijn, G. Berx, P. Vermassen et al., “The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion,” Molecular Cell, vol. 7, no. 6, pp. 1267–1278, 2001. View at Publisher · View at Google Scholar · View at Scopus
  172. J. Yang, S. A. Mani, J. L. Donaher et al., “Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis,” Cell, vol. 117, no. 7, pp. 927–939, 2004. View at Publisher · View at Google Scholar · View at Scopus
  173. L. R. Howe, O. Watanabe, J. Leonard, and A. M. Brown, “Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation,” Cancer Research, vol. 63, no. 8, pp. 1906–1913, 2003. View at Google Scholar · View at Scopus
  174. H.-W. Lo, S.-C. Hsu, W. Xia et al., “Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression,” Cancer Research, vol. 67, no. 19, pp. 9066–9076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  175. S. Thuault, U. Valcourt, M. Petersen, G. Manfioletti, C.-H. Heldin, and A. Moustakas, “Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition,” Journal of Cell Biology, vol. 174, no. 2, pp. 175–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  176. T. Shirakihara, M. Saitoh, and K. Miyazono, “Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial-mesenchymal transition induced by TGF-β,” Molecular Biology of the Cell, vol. 18, no. 9, pp. 3533–3544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  177. S. A. Mani, J. Yang, M. Brooks et al., “Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 24, pp. 10069–10074, 2007. View at Publisher · View at Google Scholar · View at Scopus
  178. M. Oft, K.-H. Heider, and H. Beug, “TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis,” Current Biology, vol. 8, no. 23, pp. 1243–1252, 1998. View at Publisher · View at Google Scholar · View at Scopus
  179. M. Oft, J. Peli, C. Rudaz, H. Schwarz, H. Beug, and E. Reichmann, “TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells,” Genes and Development, vol. 10, no. 19, pp. 2462–2477, 1996. View at Publisher · View at Google Scholar · View at Scopus
  180. W. Cui, D. J. Fowlis, S. Bryson et al., “TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice,” Cell, vol. 86, no. 4, pp. 531–542, 1996. View at Publisher · View at Google Scholar · View at Scopus
  181. G. Portella, S. A. Cumming, J. Liddell et al., “Transforming growth factor β is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion,” Cell Growth & Differentiation, vol. 9, no. 5, pp. 393–404, 1998. View at Google Scholar · View at Scopus
  182. Y. Kang and J. Massagué, “Epithelial-mesenchymal transitions: twist in development and metastasis,” Cell, vol. 118, no. 3, pp. 277–279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  183. J. Yang and R. A. Weinberg, “Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis,” Developmental Cell, vol. 14, no. 6, pp. 818–829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. S. Lamouille, J. Xu, and R. Derynck, “Molecular mechanisms of epithelial-mesenchymal transition,” Nature Reviews Molecular Cell Biology, vol. 15, no. 3, pp. 178–196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  185. J. Zavadil, M. Bitzer, D. Liang et al., “Genetic programs of epithelial cell plasticity directed by transforming growth factor-β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6686–6691, 2001. View at Publisher · View at Google Scholar · View at Scopus
  186. S. Itoh, M. Thorikay, M. Kowanetz et al., “Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses,” The Journal of Biological Chemistry, vol. 278, no. 6, pp. 3751–3761, 2003. View at Publisher · View at Google Scholar · View at Scopus
  187. E. Janda, K. Lehmann, I. Killisch et al., “Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways,” Journal of Cell Biology, vol. 156, no. 2, pp. 299–313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  188. M. Oft, R. J. Akhurst, and A. Balmain, “Metastasis is driven by sequential elevation of H-ras and Smad2 levels,” Nature Cell Biology, vol. 4, no. 7, pp. 487–494, 2002. View at Google Scholar · View at Scopus
  189. M. Adorno, M. Cordenonsi, M. Montagner et al., “A Mutant-p53/Smad complex opposes p63 to empower TGFβ-induced metastasis,” Cell, vol. 137, no. 1, pp. 87–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  190. U. Burk, J. Schubert, U. Wellner et al., “A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells,” EMBO Reports, vol. 9, no. 6, pp. 582–589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  191. M. Korpal, E. S. Lee, G. Hu, and Y. Kang, “The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2,” The Journal of Biological Chemistry, vol. 283, no. 22, pp. 14910–14914, 2008. View at Publisher · View at Google Scholar · View at Scopus
  192. S.-M. Park, A. B. Gaur, E. Lengyel, and M. E. Peter, “The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2,” Genes & Development, vol. 22, no. 7, pp. 894–907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  193. P. A. Gregory, A. G. Bert, E. L. Paterson et al., “The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1,” Nature Cell Biology, vol. 10, no. 5, pp. 593–601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  194. X. Ding, S. I. Park, L. K. McCauley, and C. Y. Wang, “Signaling between transforming growth factor β (TGF-β) and transcription factor snai2 represses expression of microRNA miR-203 to promote epithelial-Mesenchymal transition and tumor metastasis,” Journal of Biological Chemistry, vol. 288, no. 15, pp. 10241–10253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  195. J. Zavadil, M. Narasimhan, M. Blumenberg, and R. J. Schneider, “Transforming growth factor-β and microRNA:mRNA regulatory networks in epithelial plasticity,” Cells Tissues Organs, vol. 185, no. 1–3, pp. 157–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  196. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983–3988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  197. P. B. Gupta, C. L. Chaffer, and R. A. Weinberg, “Cancer stem cells: mirage or reality?” Nature Medicine, vol. 15, no. 9, pp. 1010–1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  198. S. V. Sharma, D. Y. Lee, B. Li et al., “A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations,” Cell, vol. 141, no. 1, pp. 69–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  199. C. Scheel, E. N. Eaton, S. H.-J. Li et al., “Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast,” Cell, vol. 145, no. 6, pp. 926–940, 2011. View at Publisher · View at Google Scholar · View at Scopus
  200. S. A. Mani, W. Guo, M.-J. Liao et al., “The epithelial-mesenchymal transition generates cells with properties of stem cells,” Cell, vol. 133, no. 4, pp. 704–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  201. M. Yu, A. Bardia, B. S. Wittner et al., “Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition,” Science, vol. 339, no. 6119, pp. 580–584, 2013. View at Publisher · View at Google Scholar · View at Scopus
  202. M. Pickup, S. Novitskiy, and H. L. Moses, “The roles of TGFβ in the tumour microenvironment,” Nature Reviews Cancer, vol. 13, no. 11, pp. 788–799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  203. H. Tsushima, S. Kawata, S. Tamura et al., “High levels of transforming growth factor in patients with colorectal cancer: association with disease progression,” Gastroenterology, vol. 110, no. 2, pp. 375–382, 1996. View at Publisher · View at Google Scholar · View at Scopus
  204. B. I. Dalal, P. A. Keown, and A. H. Greenberg, “Immunocytochemical localization of secreted transforming growth factor-β1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma,” The American Journal of Pathology, vol. 143, no. 2, pp. 381–389, 1993. View at Google Scholar · View at Scopus
  205. M. S. Steiner, Z.-Z. Zhou, D. C. Tonb, and E. R. Barrack, “Expression of transforming growth factor-β1 in prostate cancer,” Endocrinology, vol. 135, no. 5, pp. 2240–2247, 1994. View at Publisher · View at Google Scholar · View at Scopus
  206. R. Derynck, R. J. Akhurst, and A. Balmain, “TGF-beta signaling in tumor suppression and cancer progression,” Nature Genetics, vol. 29, pp. 117–129, 2001. View at Publisher · View at Google Scholar
  207. D. F. Quail and J. A. Joyce, “Microenvironmental regulation of tumor progression and metastasis,” Nature Medicine, vol. 19, no. 11, pp. 1423–1437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  208. L. A. Kingsley, P. G. J. Fournier, J. M. Chirgwin, and T. A. Guise, “Molecular biology of bone metastasis,” Molecular Cancer Therapeutics, vol. 6, no. 10, pp. 2609–2617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  209. J. Massagué, “TGFβ in Cancer,” Cell, vol. 134, no. 2, pp. 215–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  210. M. H. Branton and J. B. Kopp, “TGF-β and fibrosis,” Microbes and Infection, vol. 1, no. 15, pp. 1349–1365, 1999. View at Publisher · View at Google Scholar · View at Scopus
  211. P. J. Wipff and B. Hinz, “Myofibroblasts work best under stress,” Journal of Bodywork and Movement Therapies, vol. 13, no. 2, pp. 121–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  212. A. H. Rook, J. H. Kehrl, L. M. Wakefield et al., “Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness,” Journal of Immunology, vol. 136, no. 10, pp. 3916–3920, 1986. View at Google Scholar · View at Scopus
  213. L. Gorelink and R. A. Flavell, “Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells,” Nature Medicine, vol. 7, no. 10, pp. 1118–1122, 2001. View at Publisher · View at Google Scholar · View at Scopus
  214. S. Ramesh, G. M. Wildey, and P. H. Howe, “Transforming growth factor β (TGFβ)-induced apoptosis: the rise & fall of Bim,” Cell Cycle, vol. 8, no. 1, pp. 11–17, 2009. View at Google Scholar · View at Scopus
  215. F. Geissmann, P. Revy, A. Regnault et al., “TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells,” Journal of Immunology, vol. 162, no. 8, pp. 4567–4575, 1999. View at Google Scholar · View at Scopus
  216. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, “Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes,” Trends in Immunology, vol. 23, no. 11, pp. 549–555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  217. Z. G. Fridlender, J. Sun, S. Kim et al., “Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN,” Cancer Cell, vol. 16, no. 3, pp. 183–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  218. P. D. Bos, X. H. Zhang, C. Nadal et al., “Genes that mediate breast cancer metastasis to the brain,” Nature, vol. 459, no. 7249, pp. 1005–1009, 2009. View at Publisher · View at Google Scholar · View at Scopus
  219. Y. Kang, P. M. Siegel, W. Shu et al., “A multigenic program mediating breast cancer metastasis to bone,” Cancer Cell, vol. 3, no. 6, pp. 537–549, 2003. View at Publisher · View at Google Scholar · View at Scopus
  220. D. X. Nguyen, P. D. Bos, and J. Massagué, “Metastasis: from dissemination to organ-specific colonization,” Nature Reviews Cancer, vol. 9, no. 4, pp. 274–284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  221. Y. Kang, W. He, S. Tulley et al., “Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 13909–13914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  222. T. Shibue and R. A. Weinberg, “Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment,” Seminars in Cancer Biology, vol. 21, no. 2, pp. 99–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  223. J. A. Aguirre-Ghiso, “Models, mechanisms and clinical evidence for cancer dormancy,” Nature Reviews Cancer, vol. 7, no. 11, pp. 834–846, 2007. View at Publisher · View at Google Scholar · View at Scopus
  224. J. H. Tsai and J. Yang, “Epithelial-mesenchymal plasticity in carcinoma metastasis,” Genes & Development, vol. 27, no. 20, pp. 2192–2206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  225. M. Stankic, S. Pavlovic, Y. Chin et al., “TGF-β-Id1 signaling opposes twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition,” Cell Reports, vol. 5, no. 5, pp. 1228–1242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  226. J.-H. Yuan, F. Yang, F. Wang et al., “A Long Noncoding RNA Activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma,” Cancer Cell, vol. 25, no. 5, pp. 666–681, 2014. View at Publisher · View at Google Scholar · View at Scopus
  227. H. Gao, G. Chakraborty, A. P. Lee-Lim et al., “The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites,” Cell, vol. 150, no. 4, pp. 764–779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  228. R. J. Akhurst and A. Hata, “Targeting the TGFbeta signalling pathway in disease,” Nature Reviews Drug Discovery, vol. 11, pp. 790–811, 2012. View at Google Scholar